Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Ativa Raises $15 Million from China Investors for Micro Blood Test Device

publication date: Sep 24, 2015
Ativa Medical of Minneapolis, a medical diagnostic device company, raised $15 million in a B round, much of it from China investors. The company is developing the Ativa micro lab device, which miniaturizes larger, more expensive central lab blood test devices into a countertop system for use in a clinic. Results are available in five minutes. The financing was led by Ping An Ventures, the VC arm of the large China insurance company, and joined by Hermed Capital, a partnership between Fosun Pharma and SK Group of Korea; and DiAn Diagnostics, an operator of China central labs. More details....

Stock Symbols: (SHA: 600196; HK: 2196) (SHZ: 300244)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital